Dublin, Feb. 29, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/z5p4br/the_world_market) has announced the addition of the "The World Market for Microarrays" report to their offering.
Microarrays are an important tool used in functional genomics for understanding biological data. Advancements in technology have led to the development of more sophisticated techniques, instruments, data analysis, and management tools for studying genetics.
The current market is rapidly evolving with companies making substantial investments on research and development to develop new technologies and identify new therapies and diagnostic tests. Certified service providers offer microarray base services including genome-studies such as genome expression, SNP (single nucleotide polymorphism), CNV (copy-number variation), epigenetic mapping and diagnostic services.
Market players in microarray technology work closely with a broad network of service providers utilizing their technology platforms (or products, instruments or software) for successful execution of services.
The report profiles companies involved in the microarrays market, including Illumina, Affymetrix, Agilent, and bioMerieux.
World Market for Microarrays analyzes the current and future markets for microarrays, including:
- Overview of Microarrays
- Technology
- DNA Microarrays
- DNA Microarrays - High Growth Applications
- Protein Microarrays
- Lab-on-a-Chip Technology
Market analysis in this report includes the following:
- Microarray Products and Services, Worldwide, 2015
- DNA Microarray Market Growth, 2015-2020
- Lab-on-a-Chip Market Growth, 2015-2020
- Protein Microarray Market Growth, 2015-2020
- Other Microarray Market Growth, 2015-2020
- Microarray Sales by Geographic Region, 2015 (North America, Europe, Asia, ROW)
- DNA Microarray Market, Research vs. Clinical, 2015
- Lab-on-a-Chip Market, Research vs. Clinical, 2015
Key Topics Covered:
ONE: EXECUTIVE SUMMARY
1.1 Overview
1.2 Scope and Methodology
1.3 Market Overview
1.4 Future Prospects for Microarrays
TWO: MARKET DYNAMICS
2.1 Mergers and Acquisitions
2.2 Agreements with Other Companies
2.3 Market Drivers and Constraints
THREE: OVERVIEW OF MICROARRAYS
3.1 Types of Microarrays
FOUR: TECHNOLOGY
4.1 Production of Microarrays
4.2 Substrates and Surface Chemistries
4.3 Next Generation Microarrays
4.4 Data Management and Informatics in Gene Expression
FIVE: DNA MICROARRAYS
5.1 Applications
DNA Microarrays in Gene Expression
5.2 DNA Microarrays in SNP Analysis
5.3 DNA Microarrays in Cancer
5.4 Other Scanners/Readers
SIX: DNA MICROARRAYS - HIGH GROWTH APPLICATIONS
6.1 Epigenetic Mapping Arrays
6.2 Tiling Arrays
6.3 Growth of Next Generation Sequencing
SEVEN: PROTEIN MICROARRAYS
7.1 Protein Microfilling Microarrays - Antibody Arrays (Also Called Forward Phase Protein Arrays)
7.2 Protein Profiling Microarrays-Reverse Phase Microarrays or Protein Lysate Microarrays
7.3 Functional Protein Microarrays
7.4 Multiplex Sandwich Immunoassays - Planar and Bead-Based
7. 5 Specialized and High Growth Applications
7.6 New Protein Arrays or Emerging Protein Arrays - Protein Nanoarrays
Aptamer Arrays
Cell-Free Arrays
7.7 Nucleic Acid Programmable Protein Arrays
7.8 Peptoid Arrays
7.9 Applications
Drug Discovery and Development
7.10 Protein Biomarkers
7.11 Cytokine Applications
EIGHT: INTRODUCTION TO LAB-ON-A-CHIP TECHNOLOGY
8.1 Lab-on-a-Chip Technology
8.2 Applications for Lab-on-a-Chip
8.3 Barriers to Widespread Adaptation
8.4 Advantages of Lab-on-a-Chip
8.5 Patents
8.6 Trend for the Future: Lab-on-a-Chip to Enable Mobile Health (mHealth)
NINE: MARKET ANALYSIS
9.1 Overview
9.2 Market Summary
9.3 DNA Microarrays
9.4 Lab-on-a-Chip Market
9.5 Protein Microarray Market
9.6 Other Microarray Market
9.7 Sales by Region
9.8 Clinical and Research Markets
TEN: COMPANY PROFILES
Affymetrix, Inc.
Recent Revenue History
Company Overview (Focusing on Proteomics Activities)
Affymetrix Core
Recent Developments
Agilent Technologies Inc.
Recent Revenue History
Company Overview
Applied Microarrays, Inc.
Ariosa Diagnostics, Inc. (A Roche Company)
ArrayIt Corporation / Avant Diagnostics, Inc
Recent Revenue History
Company Overview
Aurora Life Sciences, LLC
Avant Diagnostics, Inc. (formerly Arrayit Diagnostics, Inc.)
Axela, Inc
AXO Science
AYOXXA Biosystems GmbH
Bio-Rad Laboratories, Inc.
Recent Revenue History
Company Overview
Caprion, Inc.
CDI Laboratories
Cepheid
Recent Revenue History
Company Overview
Hospital Acquired Infections (HAI)
TB
Infectious Diseases
Virology
Oncology
Fluidigm Corporation
Recent Revenue History
Company Overview
Recent Developments
GE Healthcare Life Sciences
Illumina
Recent Revenue History
Life Sciences
Reproductive and Genetic Health
Oncology
Enterprise Informatics
InDevR, Inc.
Luminex Corporation
Recent Revenue History
Company Overview
Nanosphere, Inc.
Company Overview
Recent Developments
Oxford Gene Technology
PerkinElmer, Inc. (PE)
Company Overview
Recent Development
Phalanx Biotech Group
RayBiotech
Recent Developments
Sequenom, Inc
Recent Revenue History
Company Overview
Recent Developments
Sigma-Aldrich Corporation
Recent Revenue History
Company Overview
SomaLogic, Inc.
SQI Diagnostics Inc.
Recent Revenue History
Company Overview
Theranostics Health Inc.
Thermo Fisher Scientific Inc.
Recent Revenue History
Company Overview
U.S Biomax, Inc.
For more information visit http://www.researchandmarkets.com/research/z5p4br/the_world_market
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies
GameStop Misses Q3 Revenue Estimates as Digital Shift Pressures Growth
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO
Nvidia Develops New Location-Verification Technology for AI Chips
Air Transat Reaches Tentative Agreement With Pilots, Avoids Strike and Restores Normal Operations
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S.
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Westpac Director Peter Nash Avoids Major Investor Backlash Amid ASX Scrutiny
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 



